Latest news about Aakaar Medical Technologies
Aakaar Medical Technologies
71.00
+0.80(+1.14%)
Company Performance:
View Company Insights1D+1.14%
1M+4.41%
6M+20.44%
1Y-9.27%
5Y-0.35%
More news about Aakaar Medical Technologies
26May 26
Aakaar Medical approves ESOP 2026, hikes share capital
Aakaar Medical Technologies Limited approved the Aakar Medical Technologies Employee Stock Option Plan 2026 for 11.33 lakh options and increased authorized share capital to ₹15.40 crore. The options are exercisable into equity shares of ₹10 each, with a vesting period of at least 12 months. Both approvals are subject to shareholder consent.
22May 26
Aakaar Medical fixes record date for 13th AGM
Aakaar Medical Technologies Limited scheduled its 13th AGM for June 30, 2026, via video conferencing. The record date for the notice is May 29, 2026, while the e-voting cut-off date is June 23, 2026.
16May 26
Aakaar Medical Technologies to Set Up Aesthetics Device Manufacturing Facility in Pune
Aakaar Medical Technologies' Board of Directors approved the company's entry into Aesthetics Device manufacturing in their meeting on May 15, 2026. The company plans to lease a facility in Pune for contract manufacturing of Aesthetics Devices. The disclosure was made to the National Stock Exchange of India Limited under Regulation 30 of SEBI (LODR) Regulations, 2015. The arrangement involves no related party transactions, no special rights, and no share issuance or loan agreements.
16May 26
Aakaar Medical Technologies Appoints M/s. NAM & ASSOCIATES as Secretarial Auditors for Five-Year Term
Aakaar Medical Technologies approved the appointment of M/s. NAM & ASSOCIATES as Secretarial Auditors at its Board meeting on May 15, 2026. The firm, holding Firm Registration No. S2016MH438800 and COP No. 17539, has been appointed for 5 consecutive years from FY2025-26 to FY2029-30, subject to shareholder approval at the ensuing Annual General Meeting. The appointment was made on the recommendation of the Audit Committee and is in compliance with SEBI Listing Regulations.
15May 26
Aakaar Medical Technologies Updates Code of Fair Disclosure Under SEBI Insider Trading Regulations
Aakaar Medical Technologies Limited's Board approved the revision of its Code of Practices and Procedures for Fair Disclosure of UPSI on May 14, 2026, under Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The policy, originally adopted on December 19, 2024 and now carrying Revision 01/2026, sets out principles for uniform UPSI dissemination, analyst interactions, compliance officer duties, and digital database maintenance. An accompanying Annexure A outlines the Policy for Determination of Legitimate Purposes for sharing UPSI. The revised code is publicly available on the company's official website.
10May 26
Aakaar Medical Technologies Submits Structured Digital Database Compliance Certificate for Financial Year Ended March 31, 2026
Aakaar Medical Technologies Limited submitted its SDD compliance certificate for the financial year ended March 31, 2026, to the National Stock Exchange of India on May 09, 2026. Certified by Devendra V Deshpande of DVD & Associates, the certificate confirms all 52 required UPSI events were captured and no non-compliance was observed. A temporary technical issue in the SDD during February 2026 was resolved promptly, with no data loss or integrity concerns, and the matter was noted by the Audit Committee.
08May 26
Aakaar Medical Technologies Schedules H2 & FY26 Earnings Call for May 15, 2026
Aakaar Medical Technologies Limited has scheduled its H2 & FY26 earnings conference call for May 15, 2026, at 4:30 PM IST, following the Board's approval of audited financial results for the year ended March 31, 2026. The call, organised by Go India Advisors, will feature Founder & MD Dilip Meswani, CEO Rahul Sawakhande, and CFO Rakesh Parekh, with pre-registration mandatory for dial-in access. The intimation was filed under SEBI Regulation 30 and submitted to NSE on May 07, 2026.
Industry Peers
Godrej Consumer Products
Dabur India
Colgate Palmolive
Cupid
P&G Hygiene and Health Care
Gillette
Emami
Mamaearth
Bajaj Consumer Care
Anondita Medicare
1,057.70
(+0.47%)
429.45
(-0.43%)
2,001.10
(-0.53%)
212.98
(-3.04%)
8,782.00
(-0.45%)
7,788.00
(-0.40%)
406.95
(-1.07%)
470.10
(-0.14%)
553.70
(-2.59%)
1,168.95
(-1.16%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
